Clarivate Plc reports developments in data, analytics and workflow software for academia and government, intellectual property, and life sciences and healthcare. Its news commonly covers earnings, subscription and recurring revenue trends, cash flow and leverage actions, and progress under its operating improvement initiatives.
Company updates also focus on AI-enabled research and decision-support products, including Web of Science Research Intelligence, Nexus Connect, Cortellis Regulatory Intelligence, Derwent-based patent analytics and other Clarivate data assets. Recurring announcements address institutional research intelligence, academic library workflows, regulatory intelligence for life sciences teams, intellectual property benchmarks and investor conference appearances.
Clarivate (NYSE: CLVT) has announced it will release its first quarter 2025 financial results on Tuesday, April 29, 2025, before market opening. The company will host a conference call and webcast at 9:00 AM Eastern Time on the same day to discuss the results.
The earnings release and supplementary financial information will be available on Clarivate's investor relations website. Interested parties can join the live webcast through the investor relations section or participate in the audio broadcast by calling 800-715-9871 (U.S.) or +1 646-307-1963 (international) using conference ID 7007526.
A replay of the webcast will be accessible on the investor relations website two hours after the call concludes and will remain available for one year.
Clarivate (NYSE:CLVT) has announced a strategic partnership with Iprova, integrating Iprova's invention creation solutions with IPfolio, Clarivate's IP management software. The partnership coincides with the release of Invention Studio 3, Iprova's enhanced AI-based invention creation tool hosted on Microsoft Azure.
The integration aims to streamline the transition of inventions into the patent workflow, creating a more collaborative environment for inventors and attorneys. The partnership represents Clarivate's commitment to improving the innovation economy by connecting knowledge and intellectual capital.
Additionally, Clarivate has acquired Rowan Patents, an AI-driven patent drafting software, further strengthening its position as a central hub for IP management. These strategic moves enhance Clarivate's ability to provide comprehensive support throughout the IP lifecycle, from invention creation to patent filing and prosecution.
Clarivate has unveiled its 2025 Top 100 Global Innovators list, highlighting organizations leading worldwide technology research and innovation. These elite companies generate $4.6 trillion in annual revenues, representing 4.4% of the global economy, with average innovation investment of 8.8% of their revenues totaling $290 billion USD.
Key findings include:
- Japan leads with 33 organizations, followed by US (18), Taiwan (13), Germany and South Korea (8 each)
- Samsung Electronics maintains #1 ranking
- Six new companies joined the list, including GE Aerospace and Caterpillar
- 16 organizations maintained all-time recipient status
New analysis reveals convergent inventions account for almost 40% of top innovations across five macro-forces: sustainability, wellbeing, mobility, connectivity, and automation. Electronics and computing equipment sector leads, followed by Semiconductors and Industrial systems.
Clarivate (NYSE: CLVT) has published a white paper analyzing the pharmaceutical industry's growth potential in Latin America. The report, titled 'How is Latin America Growing?', highlights that the region's pharmaceutical market, valued at $98 billion, is projected to grow by 10.1% between 2021 and 2025.
The study emphasizes key areas for development including strategic partnerships, local API production, and regulatory modernization. Insights were gathered from discussions at the 2023 Summit LATAM in Barcelona and 2024 Summit LATAM at CPhI Milan, focusing on collaboration between industry stakeholders, government agencies, and academia.
The report outlines critical findings including: the need for transparency in partnerships, potential of local API production to reduce import dependence, AI's role in modernizing regulatory processes, and importance of consistent policies for investment and innovation.
Clarivate (NYSE: CLVT) reported Q4 2024 results with total revenue of $663.0 million, down 3.0% from Q4 2023, with organic revenues declining 0.7%. The company posted a Q4 net loss of $191.8 million ($0.27 per share), improving from a loss of $843.9 million in Q4 2023.
For full-year 2024, revenue was $2.56 billion, down 2.7% from 2023, with organic revenues decreasing 1.4%. The company generated $357.5 million in free cash flow and executed $200 million in share repurchases and $198.1 million in debt pre-payment. The board authorized a new $500 million share repurchase program for 2025-2026.
Looking ahead to 2025, Clarivate expects revenues between $2.28B-$2.40B, with recurring organic revenue growth between -1.0% to 1.0%. The company has initiated a strategic review, including potential divestitures, and plans to discontinue certain low-margin transactional products in 2025-2026.
Clarivate (NYSE:CLVT) has announced a new subscription-based content access strategy for academic institutions. The initiative introduces two key solutions: ProQuest Ebooks, offering over 700,000 Ebooks across 10 disciplines, and ProQuest Digital Collections, providing access to over 160 million primary source items along with scholarly journals, videos, and audio tracks.
The new strategy aims to address libraries' evolving needs by providing affordable and broad access to academic resources. Key features include a new Ebook Central Reader app and AI-powered research assistants. The company will phase out one-time perpetual purchases of digital collections and books throughout 2025.
This transformation responds to post-pandemic shifts in how institutions purchase academic content and the growing importance of AI-powered tools in academic research, emphasizing the need for reliable, vetted content sources.
Clarivate Plc (NYSE:CLVT) has achieved notable recognition in the WTR 1000 2025, a prestigious guide identifying top trademark professionals globally. The company has been highly recommended in three key practice areas: Trademark Management, Searching and Watching, and Renewals and Recordals.
Francois Neuville, Senior Vice President of Brand and Trademark Solutions at Clarivate, emphasized the importance of data-driven strategies in today's evolving brand landscape. He highlighted Clarivate's exceptional data quality and expertise in providing solutions throughout the trademark lifecycle, particularly noting their use of artificial intelligence and tech-enabled services to enhance decision-making efficiency.
The WTR 1000, celebrating its 15th year, conducts thorough qualitative research to identify leading professionals and firms based on expertise, market presence, and work sophistication. Recognition is granted based on positive feedback from knowledgeable market sources.
Clarivate (NYSE: CLVT) has been selected by the National and University Library in Zagreb (NSK) to provide its unified library services and discovery platform. The implementation includes Ex Libris Alma and Ex Libris Primo solutions, which will serve as a modern, unified library system across Croatia's academic and research institutions.
The cloud-based subscription service will be implemented in nine universities and 82 academic and research libraries throughout Croatia. This strategic project, part of the e-Universities initiative, is financed through the National Recovery and Resilience Plan 2021-2026. The implementation aims to streamline existing infrastructure of multiple library systems and data formats, while promoting Croatia's cultural and scientific heritage.
Clarivate (NYSE:CLVT) has published a new e-book analyzing breakthroughs in the pulsed field ablation (PFA) market for atrial fibrillation treatment. PFA technology uses high-voltage microsecond electrical pulses instead of thermal energy, offering safer and more effective procedures compared to traditional methods.
The report highlights significant market growth projections, with PFA expected to grow from $300 million (5% market share) in 2023 to $8 billion (70% market share) by 2028. Key developments include Johnson & Johnson's VARIPULSE FDA approval in November, though its U.S. rollout was paused due to safety concerns. Abbott Laboratories is anticipated to receive FDA approval by mid-2026.
International markets show strong adoption, particularly in Asia Pacific, where the market is projected to exceed $1 billion in 3-5 years, with Japan alone potentially reaching $300 million by 2028.
Clarivate (NYSE:CLVT) has released a report identifying the top 50 universities driving global innovation through academic research and patent citations. The study, leveraging data from Web of Science and Derwent databases, reveals how knowledge flows between academia and industry across different regions.
Key findings show these universities are spread across eleven countries, with U.S. institutions dominating the top positions. Harvard University leads in research output volume, while MIT demonstrates exceptional research-to-innovation translation despite smaller publication numbers. The report identifies strong regional citation patterns, with Eastern Asian and European companies primarily citing local academic research, while U.S. research maintains global influence.
Notable insights include that five organizations - Roche, Johnson & Johnson, CNRS, Samsung Electronics, and Siemens - account for 51% of citations from top innovations to academic research. The United Kingdom shows diverse international influence, often bridging regional research gaps. The report aims to help stakeholders make informed decisions about research partnerships, knowledge transfer strategies, and innovation investments.